Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
Apr 23 10:27AM ET
Dollar change
Percentage change
Index- P/E- EPS (ttm)-2.51 Insider Own43.27% Shs Outstand63.27M Perf Week-5.66%
Market Cap277.45M Forward P/E11.62 EPS next Y0.38 Insider Trans-0.07% Shs Float35.95M Perf Month-19.53%
Income-156.23M PEG- EPS next Q-0.07 Inst Own32.01% Short Float2.19% Perf Quarter-5.04%
Sales512.35M P/S0.54 EPS this Y683.34% Inst Trans2.05% Short Ratio5.50 Perf Half Y44.48%
Book/sh2.74 P/B1.60 EPS next Y140.43% ROA-8.86% Short Interest0.79M Perf Year347.84%
Cash/sh0.58 P/C7.51 EPS next 5Y- ROE-39.47% 52W Range0.86 - 6.08 Perf YTD-16.93%
Dividend Est.- P/FCF34.77 EPS past 5Y-51.10% ROI-28.35% 52W High-28.00% Beta0.60
Dividend TTM- Quick Ratio1.01 Sales past 5Y10.81% Gross Margin62.33% 52W Low409.02% ATR (14)0.26
Dividend Ex-Date- Current Ratio1.53 EPS Y/Y TTM2.47% Oper. Margin3.30% RSI (14)35.43 Volatility5.49% 5.00%
Employees970 Debt/Eq2.36 Sales Y/Y TTM0.04% Profit Margin-30.49% Recom2.33 Target Price6.50
Option/ShortYes / Yes LT Debt/Eq2.18 EPS Q/Q81.26% Payout- Rel Volume0.45 Prev Close4.29
Sales Surprise9.25% EPS Surprise266.49% Sales Q/Q7.62% EarningsMar 12 BMO Avg Volume143.10K Price4.38
SMA20-10.49% SMA50-11.51% SMA2004.60% Trades Volume12,194 Change2.04%
Date Action Analyst Rating Change Price Target Change
Dec-07-23Upgrade Canaccord Genuity Hold → Buy $7
Aug-09-23Upgrade Craig Hallum Hold → Buy $4 → $6
Nov-22-22Downgrade Craig Hallum Buy → Hold
Nov-09-22Downgrade JP Morgan Overweight → Underweight
Nov-09-22Downgrade Canaccord Genuity Buy → Hold $18 → $6
Mar-15-22Initiated Craig Hallum Buy $30
Nov-15-21Resumed Morgan Stanley Overweight $20
Nov-10-21Resumed JP Morgan Overweight $25
Jul-01-21Downgrade Goldman Buy → Neutral $20 → $19
Mar-08-21Initiated Morgan Stanley Overweight $18
Mar-13-24 08:48AM
Mar-12-24 10:20PM
Mar-04-24 08:00AM
04:15PM Loading…
Jan-18-24 04:15PM
Jan-12-24 04:15PM
Dec-19-23 04:30PM
Dec-06-23 08:00AM
Nov-27-23 01:33AM
Nov-12-23 09:02AM
Nov-07-23 07:59AM
Oct-31-23 07:00AM
Oct-25-23 10:48AM
07:43AM Loading…
Sep-28-23 07:43AM
Sep-19-23 09:52PM
Sep-06-23 04:30PM
Aug-16-23 09:02AM
Aug-10-23 08:09AM
Aug-08-23 10:02PM
Aug-04-23 08:30AM
Aug-01-23 05:35PM
Jun-23-23 06:35PM
May-25-23 06:38AM
May-23-23 07:30AM
May-18-23 12:07PM
May-17-23 08:33AM
May-16-23 04:15PM
05:33PM Loading…
May-15-23 05:33PM
May-11-23 07:00AM
May-10-23 09:00AM
May-03-23 08:30AM
Apr-08-23 08:55AM
Apr-05-23 10:52AM
Mar-31-23 07:30AM
Mar-30-23 04:51AM
Mar-29-23 08:55AM
Mar-20-23 10:16AM
Mar-16-23 08:30AM
Feb-28-23 07:30AM
Jan-27-23 02:49PM
Jan-14-23 03:14PM
Jan-04-23 07:00AM
Dec-27-22 02:53PM
Dec-09-22 11:58AM
Nov-28-22 10:34PM
Nov-21-22 05:15PM
Nov-16-22 05:15PM
Nov-10-22 05:38AM
Nov-09-22 06:18PM
Nov-08-22 07:30AM
Oct-31-22 07:00AM
Oct-12-22 08:00AM
Aug-30-22 08:00AM
Aug-12-22 02:32AM
Aug-11-22 07:00AM
Aug-03-22 07:00AM
Jul-26-22 07:00AM
Jul-12-22 08:30AM
Jul-04-22 10:00AM
Jun-22-22 05:00AM
Jun-21-22 07:30AM
Jun-15-22 08:33AM
May-10-22 01:00PM
May-04-22 02:54PM
May-03-22 05:47PM
May-02-22 07:00AM
Apr-26-22 02:59PM
Apr-25-22 07:00AM
Apr-08-22 09:15AM
Apr-07-22 10:12PM
Apr-05-22 07:00AM
Apr-04-22 05:36PM
Apr-03-22 09:10PM
Mar-25-22 07:32AM
Mar-16-22 07:00AM
Mar-11-22 09:43AM
Mar-10-22 12:30PM
Mar-01-22 07:00AM
Feb-28-22 11:29AM
Feb-22-22 07:00AM
Feb-09-22 07:35AM
Feb-07-22 03:38PM
Feb-03-22 05:52AM
Jan-11-22 07:00AM
Bioventus, Inc. is a medical technology company, which focuses on developing and commercializing and proprietary orthobiologic products for the treatment of patients suffering from an array of musculoskeletal conditions. It operates through the following business segments: Active Healing Therapies-U.S, Active Healing Therapies-International, Surgical and BMP. The Active Healing Therapies-U.S and International offers two types of non-surgical products which are non-invasive exogen system for long bone stimulation for fracture healing and hyaluronic acid, or HA, viscosupplementation therapies for osteoarthritis pain relief. The Surgical segment offers a portfolio of advanced bone graft substitutes. The BMP segment comprises proprietary next-generation bone morphogenetic protein, or BMP. The company was founded on November 23, 2011 and is headquartered in Durham, NC.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Singleton Mark LeonardSVP & CFOApr 11 '24Sale4.754,00019,00034,665Apr 15 06:03 PM
D'Adamio AnthonySVP & General CounselApr 11 '24Sale4.753,05414,50658,242Apr 15 06:00 PM
CHURCH KATRINA JSVP & Chief Compliance OfficerApr 11 '24Sale4.751,3256,29417,042Apr 15 05:58 PM
Singleton Mark LeonardSVP & CFOMar 22 '24Sale5.395,54129,85325,665Mar 25 05:36 PM
D'Adamio AnthonySVP & General CounselMar 15 '24Sale5.463,12517,06251,371Mar 20 06:41 PM
CHURCH KATRINA JSVP & Chief Compliance OfficerMar 15 '24Sale5.461,2176,64514,067Mar 20 06:41 PM
Bihl Anthony P IIIInterim CEOAug 18 '23Buy4.1426,595110,07126,595Aug 22 06:20 PM
Bihl Anthony P IIIInterim CEOAug 18 '23Buy4.1413,29055,005138,290Aug 22 06:20 PM
Juniper Investment Company, LL10% OwnerAug 14 '23Buy4.7914,98571,7786,833,857Aug 15 04:05 PM
Bartholdson John A.DirectorAug 14 '23Buy4.7914,98571,7536,833,857Aug 15 05:48 PM
Bartholdson John A.DirectorAug 11 '23Buy4.6050,037229,9356,818,872Aug 15 05:48 PM
Juniper Investment Company, LL10% OwnerAug 11 '23Buy4.5650,037228,1696,818,872Aug 15 04:05 PM
Bartholdson John A.DirectorAug 10 '23Buy4.47111,848500,4196,768,835Aug 14 06:04 PM
Juniper Investment Company, LL10% OwnerAug 10 '23Buy4.47111,848499,9616,768,835Aug 15 04:05 PM
CHURCH KATRINA JSVP & Chief Compliance OfficerJul 03 '23Sale2.833941,11511,828Jul 05 05:11 PM
Ladone Mary KayDirectorJun 16 '23Option Exercise0.001,813020,274Jun 20 05:34 PM
McMurry-Heath MichelleDirectorJun 16 '23Option Exercise0.00386017,419Jun 20 05:21 PM
Beyer PatDirectorJun 16 '23Option Exercise0.00965018,578Jun 20 05:08 PM
Bartholdson John A.DirectorJun 15 '23Buy3.61110,180397,6626,656,987Jun 16 04:30 PM
Bartholdson John A.DirectorJun 14 '23Buy3.24181,946589,5236,546,807Jun 16 04:30 PM
Bartholdson John A.DirectorJun 13 '23Buy3.0560,324183,9106,364,861Jun 14 05:54 PM
Bartholdson John A.DirectorJun 12 '23Buy2.92395,4011,154,2556,304,537Jun 14 05:54 PM
SUTTER MARTIN PDirectorJun 06 '23Option Exercise0.0016,648028,348Jun 13 05:12 PM
NEELS GUIDO JDirectorJun 06 '23Option Exercise0.0016,648028,348Jun 08 07:32 PM
McMurry-Heath MichelleDirectorJun 06 '23Option Exercise0.0016,648017,033Jun 08 07:21 PM
Ladone Mary KayDirectorJun 06 '23Option Exercise0.0016,648018,461Jun 08 07:08 PM
HAWKINS WILLIAM ADirectorJun 06 '23Option Exercise0.0016,6480200,958Jun 08 06:57 PM
Beyer PatDirectorJun 06 '23Option Exercise0.0016,648017,613Jun 08 06:45 PM
Bartholdson John A.DirectorJun 06 '23Option Exercise0.007,57607,576Jun 08 06:27 PM
STALNECKER SUSAN MDirectorJun 06 '23Option Exercise0.0016,648049,064Jun 08 07:55 PM
NOHRA GUY PDirectorJun 06 '23Option Exercise0.0016,648028,348Jun 08 07:42 PM
HAWKINS WILLIAM ADirectorMay 25 '23Buy2.6644,000117,176184,310May 26 04:28 PM
HAWKINS WILLIAM ADirectorMay 24 '23Buy2.6944,000118,391140,310May 26 04:28 PM
Bihl Anthony P IIIInterim CEOMay 23 '23Buy2.33125,000290,988125,000May 24 09:17 PM
Bartholdson John A.DirectorMay 22 '23Buy2.08178,998372,2985,909,136May 23 09:16 PM
Bartholdson John A.DirectorMay 19 '23Buy1.941,136,6752,200,8305,730,138May 23 09:16 PM